Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition
- PMID: 3238648
Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition
Abstract
Inhibition of factor VIIa/tissue factor (TF) by extrinsic pathway inhibitor (EPI) requires the participation of factor Xa. Through this inhibition, factor Xa generated initially may feed back to suppress continuing generation of factor Xa via the extrinsic pathway during hemostasis. We have utilized chemical modifications of EPI and factor Xa to study the reactions responsible for inhibition. The data are consistent with a two-step model. First, EPI binds to factor Xa in a Ca2+ independent reaction in which the gla-domain of factor Xa does not participate. A functional active site on factor Xa and arginine residues on EPI are essential for this step. Then the factor Xa/EPI complex binds to factor VIIa/TF with resultant inhibition of its enzymatic activity. The gla-domain of factor Xa is essential for this step. Intact positively charged lysines on factor Xa may also be important.
Similar articles
-
The lipoprotein-associated coagulation inhibitor.Prog Hemost Thromb. 1991;10:243-68. Prog Hemost Thromb. 1991. PMID: 2008533 Review.
-
Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.Thromb Haemost. 1989 Feb 28;61(1):101-5. Thromb Haemost. 1989. PMID: 2665164
-
Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model.J Am Coll Cardiol. 1996 Dec;28(7):1858-65. doi: 10.1016/S0735-1097(96)00401-9. J Am Coll Cardiol. 1996. PMID: 8962577
-
The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.Thromb Haemost. 2001 Mar;85(3):458-63. Thromb Haemost. 2001. PMID: 11307815
-
Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.Haemostasis. 1991;21(4):219-39. doi: 10.1159/000216231. Haemostasis. 1991. PMID: 1794748 Review.
Cited by
-
Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits.J Clin Invest. 1996 Jul 15;98(2):325-35. doi: 10.1172/JCI118796. J Clin Invest. 1996. PMID: 8755641 Free PMC article.
-
Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.Proc Natl Acad Sci U S A. 1990 Nov;87(22):8869-73. doi: 10.1073/pnas.87.22.8869. Proc Natl Acad Sci U S A. 1990. PMID: 2247459 Free PMC article.
-
Biology of tissue factor pathway inhibitor.Blood. 2014 May 8;123(19):2934-43. doi: 10.1182/blood-2013-11-512764. Epub 2014 Mar 11. Blood. 2014. PMID: 24620349 Free PMC article. Review.
-
Tissue factor pathway inhibitor: structure-function.Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926. Front Biosci (Landmark Ed). 2012. PMID: 22201743 Free PMC article. Review.
-
Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):708-12. doi: 10.1073/pnas.88.3.708. Proc Natl Acad Sci U S A. 1991. PMID: 1899482 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous